[EN] THERAPEUTIC COMPOUNDS AND METHODS<br/>[FR] COMPOSÉS ET MÉTHODES THÉRAPEUTIQUES
申请人:[en]GENENTECH, INC.
公开号:WO2023287793A1
公开(公告)日:2023-01-19
The invention provides a compound of formula (I): or a prodrug thereof, or a pharmaceutically acceptable salt thereof, wherein R1 and R2 have any of the values described in the specification, as well as compositions comprising a compound of formula (I) or a prodrug thereof, or a pharmaceutically acceptable salt thereof. The compounds are agonists of glycolytic enzyme phosphofructokinase-1 liver type and are useful for treating diseases associated with the activity of glycolytic enzyme phosphofructokinase- 1 liver type, such as cancer, diabetes, sepsis, and septic shock.